Clinical Usefulness of the Serological Gastric Biopsy for the Diagnosis of Chronic Autoimmune Gastritis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Aim. To assess the predictive value for chronic autoimmune gastritis (AIG) of the combined assay of anti-parietal-cell antibodies (PCA), anti-intrinsic-factor antibodies (IFA), anti-Helicobacter pylori(Hp) antibodies, and measurement of blood gastrin.Methods. We studied 181 consecutive patients with anemia, due to iron deficiency resistant to oral replacement therapy or to vitamin B12 deficiency.Results. 83 patients (45.8%) tested positive for PCA and underwent gastroscopy with multiple gastric biopsies. On the basis of the histological diagnosis, PCA-positive patients were divided into 4 groups: (1) 30 patients with chronic atrophic gastritis; they had high concentrations of PCA and gastrin and no detectable IFA; (2) 14 subjects with metaplastic gastric atrophy; they had high PCA, IFA, and gastrin; (3) 18 patients with nonspecific lymphocytic inflammation with increased PCA, normal gastrin levels, and absence of IFA; (4) 21 patients with multifocal atrophic gastritis with “borderline” PCA, normal gastrin, absence of IFA and presence of anti-Hp in 100% of the cases.Conclusions. The assay of four serological markers proved particularly effective in the diagnostic classification of gastritis and highly correlated with the histological profile. As such, this laboratory diagnostic profile may be considered an authentic “serological biopsy.”
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185 · cited 3×
“In conclusion, autoimmune gastritis is a frequently asymptomatic disease that can cause atrophy of the gastric mucosa and in approximately 10% of cases evolve into a carcinoid tumour or adenocarcinoma [1, 26].”
BackgroundMethodTozzoli, R., Kodermaz, G., Perosa, A. R., Tampoia, M., Zucano, A., Antico, A., & Bizzaro, N. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.08.006 · Cited by 128
Self-citationVaris, K., Ihamäki, T., Härkönen, M., Samloff, I. M., & Siurala, M. (1979) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527909179858 · Cited by 93 · cited 1×
“” It should be noted that patients with nonspecific gastritis were younger than those with AIG, but with comparable PCA and anti-Hp positivity; this suggests the need to monitor the patients showing such histological profile by serology, for example, once a year, since AIG may occur in some of them, especially if they…”
Background
Cited by
Autoimmune atrophic gastritis—pathogenesis, pathology and management
Neumann, W. L., Coss, E., Rugge, M., & Genta, R. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.101 · Cited by 406
How I treat unexplained refractory iron deficiency anemia
Hershko, C., & Camaschella, C. (2014) · Blood · doi:10.1182/blood-2013-10-512624 · Cited by 170
Kulnigg-Dabsch, S. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0515-5 · Cited by 98
Frommer, L., & Kahaly, G. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00602 · Cited by 86
Prevalence of autoimmune gastritis in individuals undergoing medical checkups in Japan
Notsu, T., Adachi, K., Mishiro, T., Fujihara, H., Toda, T., Takaki, S., & Kinoshita, Y. (2019) · Internal Medicine · doi:10.2169/internalmedicine.2292-18 · Cited by 82
Pittman, M. E., Voltaggio, L., Bhaijee, F., Robertson, S. A., & Montgomery, E. A. (2015) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000481 · Cited by 56
Metadata
- Authors
- Antico, A., Tampoia, M., Villalta, D., Tonutti, E., Tozzoli, R., & Bizzaro, N.
- Venue
- Clinical and Developmental Immunology
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-5
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- OpenAlex
- W2054611055
- Cited by
- 53
- References
- 3
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.